Introdução
In pharmaceutical primary packaging, selecting the right container system is a critical decision that directly impacts drug stability, patient safety, manufacturing efficiency, and overall product lifecycle costs. Among the most widely used packaging formats globally are vials (commonly known as Xilin vials in the Chinese market) and cartridges (also referred to as cartridge bottles or dual-chamber cartridges). Each format offers distinct advantages and presents unique limitations depending on the drug product, route of administration, and market requirements.
This article provides an in-depth, evidence-based comparison of vials and cartridges, examining their structural characteristics, performance attributes, manufacturing considerations, and application scenarios. Drawing on international pharmacopoeia standards, industry best practices, and technical literature, we aim to help pharmaceutical manufacturers make informed packaging decisions. At Zhengzhou PharGlass, we specialize in both vial and cartridge primary packaging solutions, offering high-quality glass containers, rubber stoppers, and aluminum plastic caps that meet global regulatory requirements.
Part 1: Vials (Xilin Vials) – The Industry Workhorse
1.1 Definition and Construction
Vials are small glass or plastic containers with a neck that is sealed with a rubber stopper and an aluminum or plastic overseal. In the pharmaceutical context, the term “vial” almost exclusively refers to glass vials, typically manufactured from borosilicate or soda-lime glass. Vials are used for liquid injectable drugs, lyophilized (freeze-dried) powders, oral liquids, and diagnostic reagents. The most common format is the tubular glass vial, formed from glass tubing, although molded vials are also available for larger volumes.
Zhengzhou PharGlass offers a comprehensive range of pharmaceutical glass vials in sizes from 2mL to 100mL, manufactured from Type I medium borosilicate glass or Type III soda-lime glass, with or without screw necks (for oral liquids) and with various neck finishes (ISO 8362 standard).
1.2 Advantages of Vials
(1) Mature Manufacturing Technology and Proven Performance
Vials represent one of the oldest and most well-established primary packaging formats in the pharmaceutical industry. The manufacturing processes for glass vials—both tubular and molded—have been refined over decades, resulting in highly consistent dimensions, predictable mechanical properties, and reliable chemical durability. According to ISO 8362-1 (Injection containers for injectables – Glass vials), vial dimensions, neck finishes, and closure compatibility are standardized globally, enabling seamless integration into high-speed filling lines.
The production of tubular vials involves two steps: first, drawing precision glass tubing (via Vello or Danner processes), then converting tubing into vials on automatic forming machines. This process yields vials with thin, uniform walls, excellent dimensional accuracy, and smooth inner surfaces that minimize drug-container interaction. For lyophilized products, the thin glass wall of tubular vials promotes efficient heat transfer during freeze-drying cycles.
The physical robustness of vials—subject to quality control measures such as annealing (to relieve internal stresses) and surface treatment (e.g., sulfur treatment to improve surface durability)—ensures that vials can withstand the rigors of automated filling, capping, labeling, and transport. Pharmaceutical vials are tested for vertical load resistance, internal pressure resistance, thermal shock resistance, and hydrolytic resistance in accordance with USP <660>, EP 3.2.1, and ChP standards.
(2) Excellent Sealing Integrity
Vials are closed with elastomeric stoppers (e.g., chlorobutyl or bromobutyl rubber) and secured with aluminum or aluminum-plastic flip-off caps. This closure system, when properly selected and applied, provides an outstanding barrier against oxygen, moisture, and microbial ingress. The stopper forms a compression seal against the vial’s neck finish, and the crimped aluminum cap locks the stopper in place.
Sealing integrity is critical for sterile injectable products, especially those sensitive to oxidation or moisture. Vial systems can achieve leak rates well below the threshold detectable by dye ingress tests (typically <10⁻⁶ mbar·L/s). For lyophilized products stored under vacuum or nitrogen overlay, vial stopper systems are designed to maintain headspace conditions throughout the shelf life.
Zhengzhou PharGlass offers stoppers with various formulations, including coated stoppers (e.g., FluroTec®-equivalent barrier films) to reduce leachables and adsorption, as well as ready-to-use (RTU) nested stoppers for high-speed aseptic filling.
(3) Wide Range of Sizes and High Adaptability
Vials are available in an extensive array of capacities, from 2mL (small sample size) up to 100mL or more. Common sizes include 2mL, 5mL, 7mL, 10mL, 15mL, 20mL, 30mL, 50mL, and 100mL. This broad spectrum allows pharmaceutical manufacturers to select precisely the right container volume for a given drug presentation, minimizing headspace (which can cause oxidation) while avoiding excessive overfill.
Moreover, vials can be produced with different neck finishes (e.g., 13mm, 20mm, 28mm, 32mm) to accommodate different stopper sizes and closure systems. The availability of clear (flint) and amber (UV-protective) glass further expands adaptability. Molded vials, typically used for larger volumes (20mL and above), have thicker walls and higher mechanical strength, suitable for oral liquids or large-volume parenterals.
The dimensional standardization of vials means that filling lines, capping machines, labeling equipment, and visual inspection systems are widely available from multiple vendors, reducing capital expenditure and simplifying technology transfer.
1.3 Disadvantages of Vials
(1) Fragility and Weight
Glass vials are inherently fragile. While medium borosilicate and soda-lime glasses possess considerable mechanical strength when properly annealed, they are susceptible to breakage under impact, excessive vertical load, or thermal shock. Breakage can occur during:
- Automated filling and capping (due to mechanical misalignment or excessive chuck pressure)
- Lyophilization (if vials are not properly placed or if thermal gradients are extreme)
- Transport and handling (vibration, stacking pressure, or drops)
Broken vials lead to product loss, contamination of adjacent vials (in the case of liquid splashes), and potential downtime for cleaning filling lines. The weight of glass vials also contributes to higher shipping costs compared to some alternative materials (e.g., polymer-based containers). For large-volume shipments of filled vials, the cumulative weight of the glass can be substantial, affecting freight economics.
To mitigate fragility, Zhengzhou PharGlass applies stringent quality control, including automated inspection for cracks, checks, and dimensional defects. We also offer vials with external coating (e.g., silicone or polymer-based coatings) that provide a degree of protection against scratching and surface damage, though they do not eliminate breakage risk entirely.
(2) Fixed Shape Limited Design Flexibility
Unlike plastic containers that can be blow-molded into virtually any shape, glass vials are constrained by the manufacturing process. Tubular vials are essentially a cylinder with a formed neck—their geometry is cylindrical, with limited ability to create ergonomic grips, unique contours, or branding elements directly on the glass surface. Molded vials offer slightly more shape variety (e.g., oval cross-sections), but still far less than polymeric alternatives.
This fixed shape can be a disadvantage for products targeting differentiated market positioning or patient-centric designs. For example, oral liquid formulations may benefit from a bottle with an integrated measuring cup or a non-slip grip, features not easily achieved with standard glass vials. While labeling and shrink sleeves can add branding, the underlying glass container remains a simple cylinder.
Furthermore, the neck finish of vials is standardized, meaning that any deviation from the ISO dimensions would make the vial incompatible with industry-standard stoppers and caps. Thus, customizing vial shape is rarely feasible in commercial-scale pharmaceutical packaging.
Part 2: Cartridge Bottles (Cartridges) – The Modern Alternative
2.1 Definition and Construction
Cartridges (often referred to as cartridge bottles, syringe cartridges, or simply “cartridges”) are cylindrical glass containers open at both ends—one end is sealed with a rubber plunger, the other end with a rubber disc and an aluminum cap. Cartridges are primarily used in injetores tipo caneta e autoinjetores for self-administered drugs, such as insulin, growth hormones, anticoagulants (e.g., enoxaparin), and monoclonal antibodies. The cartridge is inserted into a reusable or disposable injection pen; when the pen is activated, the plunger moves forward, expelling the drug through a needle attached to the cartridge’s septum.
Cartridges are almost exclusively made from Type I borosilicate glass due to the high chemical sensitivity of biotech drugs and the need for dimensional precision (the internal diameter must be exact to ensure smooth plunger movement). Zhengzhou PharGlass manufactures glass cartridges in standard sizes (1.5mL, 3mL, 5mL, 10mL, 20mL, 50mL) with ISO 11040-4 compliance.
2.2 Advantages of Cartridges
(1) Excellent Transparency and Aesthetic Appeal
Like all pharmaceutical glass, cartridges made from borosilicate glass offer exceptional clarity. However, because cartridges are typically smaller and used directly in pen injectors that patients handle, the transparency takes on an added dimension: it allows patients to see the remaining volume of drug, check for discoloration or particles, and verify that the drug has not frozen or degraded.
The sleek, cylindrical shape of cartridges, combined with the transparency of Type I glass, conveys a sense of precision and modernity. Many cartridge-based pen injectors are designed with a viewing window that exposes the glass cartridge, allowing the user to observe the drug directly. This enhances the patient’s trust and confidence in the product’s quality.
Additionally, cartridges can be manufactured in flint (clear) or amber glass, with the amber variant providing UV protection for light-sensitive biologics. The optical quality of borosilicate glass ensures minimal distortion, unlike some polymer cartridges.
(2) Superior Sealing Performance with Oxidation and Moisture Barrier
Cartridge closure systems are highly sophisticated. The plunger (rubber stopper at the back) and the tip cap (rubber disc with an aluminum crimp) create a dual-seal environment. When properly designed and assembled, cartridges achieve excellent barrier properties against oxygen and moisture.
For drugs that are highly sensitive to oxidation (e.g., many biotech molecules containing methionine or cysteine residues), the low oxygen transmission rate (OTR) of glass—essentially zero for direct permeation—combined with the elastomeric seals, provides a nearly hermetic seal. The moisture vapor transmission rate (MVTR) is also negligible, preserving the drug’s water content or preventing moisture ingress for lyophilized formulations reconstituted directly in the cartridge (dual-chamber cartridges).
Moreover, the sealing system in cartridges is specifically designed to withstand multiple punctures by injection pens (in the case of multi-dose cartridges) without compromising sterility or allowing microbial ingress. The elastomeric septum self-heals after each needle puncture, making cartridges ideal for multi-dose regimens.
(3) Lightweight, Easy-to-Use, and Break-Resistant
One of the most frequently cited advantages of cartridges is their light weight relative to vials of comparable fill volume. A 3mL cartridge weighs significantly less than a 3mL vial plus its external packaging. This weight reduction translates into lower shipping costs, reduced carbon footprint, and easier handling for patients.
Cartridges are also less prone to breakage than vials for several reasons. First, cartridges are often used inside a rigid plastic pen injector body, which provides physical protection. Second, cartridges are typically shorter and have a thicker wall-to-diameter ratio compared to vials of similar volume, enhancing mechanical strength. Third, the absence of a neck (cartridges have uniform diameter) eliminates stress concentration points that are common failure sites in vials.
The ease of use is paramount for self-injecting patients, particularly those with chronic conditions like diabetes or rheumatoid arthritis. Cartridge-based pens require no manual handling of a glass syringe—the user simply attaches a needle, dials a dose, and injects. This reduces the risk of needle-stick injuries, breakage during drug draw-up, and dosage errors.
2.3 Disadvantages of Cartridges
(1) Higher Manufacturing Cost and Processing Complexity
Cartridges are significantly more expensive to produce than vials. The reasons include:
- Precision tubing requirements: Cartridges require glass tubing with extremely tight tolerances on inner diameter (ID) and outer diameter (OD), typically ±0.01mm, to ensure smooth plunger movement and seal integrity. This demands high-quality glass tubing from specialized suppliers.
- Double open-end processing: Unlike vials, which have a closed bottom and an open neck, cartridges are open at both ends. Forming both ends with precision, applying silicone lubrication to the inner surface (for plunger glide), and assembling two separate rubber components (plunger and tip cap) add manufacturing steps.
- Silicone application: To ensure consistent glide force, the inner surface of cartridges is coated with a controlled amount of silicone oil (either sprayed, wiped, or cross-linked). This requires specialized equipment and quality control to avoid excessive silicone particles that could leach into the drug.
- Cleaning and sterilization: Both ends of cartridges must be protected from contamination during transport and filling. Cartridges are often supplied in nested tubs or trays, which adds packaging and logistics costs.
According to industry estimates, a cartridge system can cost 2–3 times more than a vial-based system of equivalent capacity when fully assembled (glass + rubber + cap + assembly). For generic drugs or low-margin products, this cost differential can be prohibitive.
Zhengzhou PharGlass optimizes cartridge manufacturing using automated inspection systems (camera-based ID/OD measurement, wall thickness uniformity, surface defect detection) to reduce waste and ensure consistent quality, but the inherent cost remains higher than that of vials.
(2) Limited Capacity Range and Inflexible Sizing
Cartridges are available in a narrower range of volumes compared to vials. The most common sizes are 1.5mL, 3mL, 5mL, 10mL, 20mL, and 50mL. Volumes below 1mL are challenging due to the need for a robust plunger and sufficient drug delivery accuracy. Volumes above 50mL become impractical because the cartridge would be too long for ergonomic pen injector design.
Moreover, cartridges do not allow easy adjustment of fill volume without retooling. A vial of a given size can accommodate a range of fill volumes (e.g., a 10mL vial can be filled with 5mL, 7mL, or 10mL without changing the container). In contrast, a cartridge’s design is closely tied to the intended dose volume—the plunger travel distance must be precisely matched to the delivered volume. Changing the fill volume typically requires a new cartridge length and associated pen injector modifications.
This inflexibility is a significant disadvantage for drug developers who anticipate multiple presentations or who are in early clinical stages where fill volumes may change. Vials offer much greater flexibility for early-phase clinical trials and for drugs that are dosed variably (e.g., weight-based dosing requiring different vial sizes).
Part 3: Selection Considerations for Pharmaceutical Manufacturers
When deciding between vials and cartridges, Zhengzhou PharGlass recommends evaluating the following factors:
| Factor | Vials | Cartuchos |
|---|---|---|
| Primary indication | Hospital-administered injectables, lyophilized drugs, large volumes | Self-administered chronic care, pens/auto-injectors, small volumes (≤5mL) |
| Dosing frequency | Single-dose or multi-dose (with preservatives) | Multi-dose pen systems (up to 30 days) |
| Manufacturing cost | Low to moderate | High |
| Fill volume flexibility | High (2mL–100mL) | Low (mostly 1.5mL–5mL) |
| Breakage risk | Moderate to high | Low (when used in pens) |
| Patient convenience | Requires manual syringe draw-up | Pre-filled pen, no draw-up needed |
| Regulatory precedent | Extensive global approvals | Well-established for biologics, insulin |
| Packaging line speed | Up to 600 vials/min | Typically slower (cartridge handling more delicate) |
For emerging therapies such as mRNA vaccines (which are often lyophilized and require multi-dose vials), vials remain the dominant choice. For monoclonal antibodies administered subcutaneously for chronic autoimmune diseases, cartridges with pen injectors have become the patient-preferred format.
Part 4: Zhengzhou PharGlass Capabilities
Em Zhengzhou PharGlass, we supply both high-quality pharmaceutical vials and glass cartridges, manufactured under ISO 9001 and ISO 15378 (GMP for primary packaging materials). Our offerings include:
- Vials: Type I medium borosilicate and Type III soda-lime, 2mL–100mL, clear or amber, with 13mm–32mm neck finishes. We provide compatible rubber stoppers (chlorobutyl, bromobutyl, coated) and aluminum/plastic caps (flip-off, snap-on, sterile or non-sterile).
- Cartuchos: Type I borosilicate, 1.5mL–50mL, with ready-to-use nest and tub systems. Silicone lubrication levels customizable (standard or low-silicone for biologics sensitive to silicone). Complete closure sets including plungers and tip caps with aluminum crimps.
We support OEM/ODM customization, including printing on vials (ceramic ink), custom vial dimensions, and cartridge length modifications. Global shipping with appropriate protective packaging is available.
For technical guidance on selecting the optimal primary packaging for your drug product, please contact our team. We provide extractables/leachables data, dimensional drawings, and compatibility studies upon request.
Conclusão
Both vials and cartridges have established roles in pharmaceutical packaging, and neither is universally superior. Vials offer unmatched versatility, low cost, and a mature global supply chain, making them the default choice for hospital-based injectables, lyophilized products, and large-volume parenterals. Their limitations—fragility, weight, and fixed shape—are manageable through careful handling and appropriate secondary packaging.
Cartridges, on the other hand, excel in patient-centric applications where self-administration, convenience, and dosing accuracy are paramount. Their higher cost and limited size range are justified by the clinical benefits of pen injector systems, particularly for biologics and chronic disease treatments.
Ultimately, the choice between a vial and a cartridge should be driven by the drug product’s physicochemical properties, intended patient population, dosing regimen, and commercial strategy. Zhengzhou PharGlass stands ready to support pharmaceutical manufacturers with both packaging formats, backed by technical expertise, regulatory compliance, and a commitment to quality.
Referências
- ISO 8362-1:2018 – Injection containers for injectables – Glass vials
- ISO 11040-4:2015 – Prefilled syringes – Part 4: Glass barrels for prefilled syringes (cartridges)
- USP – Recipientes — Vidro
- USP <381> – Elastomeric closures for injections
- Relatório Técnico da PDA n.º 77 – Teste de integridade da vedação de recipientes
- Selection of Primary Packaging for Parenteral Products, Pharmaceutical Technology, 2021
- Industry benchmarking data on breakage rates in vial filling lines (PDA survey, 2022)
For more information on Zhengzhou PharGlass vials and cartridges, please refer to our product catalog or contact our technical support team.
PT 
EN 
FR 
AR 
DE 
ES 
FA 
RU